Subclinical hyperthyroidism when presenting as initial manifestation of juvenile Hashimoto's thyroiditis: first report on its natural history.
BACKGROUND
Due to the lack of specific pediatric studies, no data are available about natural history of endogenous subclinical hyperthyroidism (SH) in childhood.


OBJECTIVE
(a) To investigate for the first time the natural history of SH [suppressed thyrotropin (TSH) and normal free thyroxine free thyroxine (FT4) levels] when presenting as initial manifestation of Hashimoto's thyroiditis (HT) in childhood (group A); (b) to compare spontaneous evolution of HT-related SH with that observed in age-matched patients with HT-related frank hyperthyroidism (suppressed TSH and elevated FT4 levels), i.e., Hashitoxicosis Htx (group B).


RESULTS
In the 11 patients of group A, TSH normalization spontaneously occurred 1-24 months after diagnosis, while in the 10 patients of group B it occurred 3-9 months after diagnosis, with no differences between the 2 groups in terms of time interval from entry to TSH normalization. In group A, this time interval was related to baseline thyroid peroxidase antibodies (r=0.78, p = 0.04). During follow-up, eight patients of each group remained euthyroid, whereas two became hypothyroid (in both groups) and one developed Graves' disease (in group A).


CONCLUSIONS
(a) HT should be included among the causes of endogenous SH in pediatric age; (b) in children with HT-related SH, spontaneous normalization of TSH levels occurs within the first 24 months after diagnosis, as well as in age-matched patients with Htx; (c) in both these conditions, a further deterioration of thyroid function might re-present in some patients during follow-up; (d) Ht-related SH and Htx might be possibly seen as different biochemical stages along the same continuum.
T
T
Aversa
M
M
Valenzise
A
A
Corrias
M
M
Salerno
A
A
Mussa
D
D
Capalbo
G
G
Salzano
F
F
De Luca
M
M
Wasniewska
D000293:Adolescent; D001323:Autoantibodies / Q000097:blood; D002648:Child; D003430:Cross-Sectional Studies; D005260:Female; D005500:Follow-Up Studies; D050031:Hashimoto Disease / Q000150:complications*; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis* / Q000209:etiology; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D013963:Thyroid Hormones / Q000097:blood
D001323:Autoantibodies; D013963:Thyroid Hormones